Quantitative ultrasound in the assessment of bone status of patients suffering from rheumatic diseases

Skeletal Radiology

Volumn 31, Issue 5, 2002, Pages 270-276

  Lernbass, I ^a   Wutzl, A ^a   Grisar, J ^a   Schett, G ^a   Redlich, K ^a   Spitzauer, S ^a   Grampp, S ^a   Imhof, H ^a   Peterlik, M ^a   Pietschmann, P ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bone loss; Dual energy X ray absoptiometry; Glucocorticoids; Inflammation markers; Rheumatic disease; Ultrasound

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COLLAGEN TYPE 1; CREATININE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANALYTIC METHOD; ANALYTICAL PARAMETERS; ARTICLE; BONE MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEMUR NECK; HUMAN; INTERMETHOD COMPARISON; LUMBAR SPINE; OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS, RHEUMATOID; BONE AND BONES; BONE DENSITY; CALCANEUS; CASE-CONTROL STUDIES; DENSITOMETRY, X-RAY; FEMALE; FEMUR NECK; GLUCOCORTICOIDS; HUMANS; LUMBAR VERTEBRAE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREMENOPAUSE;

EID: 0036937912     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-002-0476-1     Document Type: Article

References (44)

1. Hooyman JR, Melton LJ III, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis: a population-based study. Arthritis Rheum 1984; 27:1353-1361.
2. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 1993; 306:558.
3. Epstein S. Serum and urinary markers of bone remodelling: assessment of bone turnover. Endocr Rev 1988; 9:437-449.
4. Faulkner KG, Glüer CC, Majumdar S, Lang P, Engelke K, Genant HK. Noninvasive measurements of bone mass, structure, and strength: current methods and experimental techniques. AJR 1991; 157:1229-1237.
5. Massie A, Reid DM, Porter RW. Screening for osteoporosis: comparison between dual-energy X-ray absorptiometry and broadband ultrasound attenuation in 1000 perimenopausal women. Osteoporos Int 1993; 3:107-110.
6. Tromp M, Smit JH, Deeg DJH, Lips P. Quantitative ultrasound measurements of the tibia and calcaneus in comparison with DXA measurements at various skeletal sites. Osteoporos Int 1999; 9:230-235.
7. Rand T, Schneider B, Grampp S, Wunderbaldinger P, Migsits H, Imhof H. Influence of osteophytic size on bone mineral density measured by dual x-ray absorptiometry. Acta Radiol 1997; 38:210-213.
8. Glüer C, Wu C, Jergas M, Goldstein S, Genant H. Three quantitative ultrasound parameters reflect bone structure. Calcif Tissue Int 1994; 55:45-52.
9. Faulkner KG, Glüer CC, Majumdar S, Lang P, Engelke K, Genant HK. Noninvasive measurements of bone mass, structure, and strength: current methods and experimental techniques. AJR Am J Roentgenol 1991; 157:1229-1237.
10. Heaney RP, Avioli LV, Chestnut CH, Lappe J, Recker R, Brandenburger GH. Osteoporotic bone fragility: detection by ultrasound transmission velocity. JAMA 1989; 261:2986-2990.
11. Hans D, Dargent Molina P, Schott AM, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 1996; 348:511-514.
12. Glüer CC, WU CY; Genant HK. Broadband ultrasound attenuation signals depend an trabecular orientation: an in vitro study. Osteoporos Int 1993; 3:185-191.
13. Rickers H, Deding AA, Christiansen C, Rodbro P. Mineral loss in cortical and trabecular bone during high-dose prednisolone treatment. Calcif Tissue Int 1984; 36:269-273.
14. Gallagher JC, Aaron J, Horsman A, et al. Corticosteroid osteoporosis. Clin Endocrinol 1973; 2:355-368.
15. Hahn TJ. Corticosteroid-induced osteopenia. Arch Intern Med 1978; 138:882-885.
16. Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ. Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1979; 1: 303-311.
17. Hahn TJ, Halstead LR, Teitelbaum SL, Han BH. Altered mineral metabolism in glucocorticoid-induced osteopenia: effect of 25-hydroxyvitamin D administration. J Clin Invest 1979; 64: 655-665.
18. Eastell R, Rei DM, Compston J, et al. A UK consensus group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998; 244:271-292.
19. Blanckaert F, Cortet B, Coquerelle P, et al. Contribution of calcaneal ultrasonic assessment to the evaluation of postmenopausal and glucocorticoid-induced osteoporosis. Rev Rhum Engl Ed 1997;64:305-313.
20. Gough A, Sambrook P, Delvin J, et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 1998; 25:1282-1289.
21. Emery P, Luqmani R. The validity of surrogate markers in rheumatic disease. Br J Rheumatol 1993; 32(Suppl 3):3-8.
22. Sambrook P, Raj A, Hunter D, Naganathan V, Mason R, Robinson B. Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. J Rheumatol 2001; 28:1063-1067.
23. Martin JC, Munro R, Campell MK, Reid DM. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 1997; 36: 43-49.
24. Eastell R. Management of corticosteroid-induced osteoporosis. J Intern Med 1995; 237:439-447.
25. Kirwan JR, Reeback JS. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986; 25:206-209.
26. Hoshino H, Takahashi M, Kushida K, Ohishi T, Inoue T. Urinary excretion of type I collagen degradation products in healthy women and osteoporotic patients with vertebral and hip fractures. Calcif Tissue Int 1998; 62:36-39.
27. Bauer DC, Sklarin PM, Stone KL, et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the Study of Osteoporotic Fractures. J Bone Miner Res 1999; 14:1404-1410.
28. Vogel JM, Wasnich RD, Ross PD. The clinical relevance of calcaneus bone mineral measurements: a review. Bone Miner 1988; 5:35-58.
29. WHO study group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series. Geneva: World Health Organization, 1994.
30. Kröger H, Lunt M, Reeve J, et al. Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: the European Quantitation of Osteoporosis Study. Calcif Tissue Int 1999; 64:191-199.
31. Glüer C, for the International Quantitative Ultrasound Consensus Group. Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. J Bone Miner Res 1997; 12:1280-1288.
32. Kang C, Paley M, Ordidge R, Speller R. In vivo MRI measurements of bone quality in calcaneus: a comparison with DXA and ultrasound. Ostoporos Int 1999; 9:65-74.
33. Wu C, Glüer C, Lu Y, Fuerst T, Hans D, Genant HK. Ultrasound characterization of bone demineralization. Calcif Tissue Int 1998; 62:133-139.
34. England AJ, Reid DM. Utility of peripheral bone mass measurements in rheumatoid arthritis [abstract]. Osteoporos Int 1996; 6(Suppl 1):205.
35. Njeh CF, Boivin CM, Gough A, et al. Evaluation of finger ultrasound in the assessment of bone status with application to rheumatoid arthritis. Osteoporos Int 1999; 9:82-90.
36. Njeh CF, Hodgskinson R, Currey JD, Langton CM. Orthogonal relationship between ultrasonic velocity and material properties of bovine cancellous bone. Med Eng Phys 1996; 18:373-381.
37. Madsen OR, Egsmose C, Hansen B, Sorensen OH. Soft tissue composition, quadriceps strength, bone quality and bone mass in rheumatoid arthritis. Clin Exp Rheumatol 1998; 16:27-32.
38. Goldring SR, Gravallese EM. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 2000; 12:195-199.
39. Gough A, Sambrook P, Devlin J, et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatic arthritis. J Rheumatol 1998; 25: 1282.
40. Coombes GM, Ingle B, Bax DE, Eastell R. Relationship of bone ultrasound measurements to bone mineral density in steroid treated women with rheumatoid arthritis [abstract]. Br J Rheumatol 1997; 36(Suppl 2): 23.
41. Grampp S, Genant HK, Mathur A, Lanf P, et al. Comparisons of noninvasive bone mineral measurement in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res 1997; 12:697-711.
42. Kleerekoper M, Nelson DA. Which bone density measurement? J Bone Miner Res 1997; 12:712-714.
43. Hans D, Fuerst T, Lang T, et al. How can we measure bone quality? Baillieres Clin Rheumatol 1997; 11: 495-515.
44. Glüer C, for the International Quantitative Ultrasound Consensus Group. Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. J Bone Miner Res 1997; 12:1280-1288.